siliq

Generic: brodalumab

Labeler: bausch health us llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name siliq
Generic Name brodalumab
Labeler bausch health us llc
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

brodalumab 210 mg/1

Manufacturer
Bausch Health US LLC

Identifiers & Regulatory

Product NDC 0187-0004
Product ID 0187-0004_c9a0dc71-df40-4d05-8ba8-33bfdc068a5d
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761032
Listing Expiration 2027-12-31
Marketing Start 2017-02-15

Pharmacologic Class

Established (EPC)
interleukin-17 receptor a antagonist [epc]
Mechanism of Action
interleukin 17 receptor a antagonists [moa]
Chemical Structure
antibodies, monoclonal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01870004
Hyphenated Format 0187-0004

Supplemental Identifiers

RxCUI
1872256 1872261
UNII
6ZA31Y954Z
NUI
N0000193276 N0000193279 M0001357

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name siliq (source: ndc)
Generic Name brodalumab (source: ndc)
Application Number BLA761032 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 210 mg/1
source: ndc
Packaging
  • 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00)
source: ndc

Packages (1)

0187-0004-02 2 SYRINGE in 1 CARTON (0187-0004-02) / 1 INJECTION in 1 SYRINGE (0187-0004-00)

Ingredients (1)

brodalumab (210 mg/1)

Linked Drug Pages (1)

Siliq ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "c9a0dc71-df40-4d05-8ba8-33bfdc068a5d", "openfda": {"nui": ["N0000193276", "N0000193279", "M0001357"], "unii": ["6ZA31Y954Z"], "rxcui": ["1872256", "1872261"], "spl_set_id": ["1a550c33-456a-4833-814e-8591aea7c688"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Interleukin-17 Receptor A Antagonist [EPC]"], "pharm_class_moa": ["Interleukin 17 Receptor A Antagonists [MoA]"], "manufacturer_name": ["Bausch Health US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE in 1 CARTON (0187-0004-02)  / 1 INJECTION in 1 SYRINGE (0187-0004-00)", "package_ndc": "0187-0004-02", "marketing_start_date": "20170215"}], "brand_name": "Siliq", "product_id": "0187-0004_c9a0dc71-df40-4d05-8ba8-33bfdc068a5d", "dosage_form": "INJECTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Interleukin 17 Receptor A Antagonists [MoA]", "Interleukin-17 Receptor A Antagonist [EPC]"], "product_ndc": "0187-0004", "generic_name": "Brodalumab", "labeler_name": "Bausch Health US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Siliq", "active_ingredients": [{"name": "BRODALUMAB", "strength": "210 mg/1"}], "application_number": "BLA761032", "marketing_category": "BLA", "marketing_start_date": "20170215", "listing_expiration_date": "20271231"}